Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MER-3101 by Mercia Pharma for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
MER-3101 is under clinical development by Mercia Pharma and currently in Phase I for Type 1 Diabetes (Juvenile Diabetes). According...